Mesoporous bioactive glass as a multifunctional system for bone regeneration and controlled drug release

Journal of Applied Biomaterials and Functional Materials

Volumn 10, Issue 1, 2012, Pages 12-21

  Baino, Francesco ^a   Fiorilli, Sonia ^a   Mortera, Renato ^a   Onida, Barbara ^a   Saino, Enrica ^b   Visai, Livia ^b,c,d   Verné, Enrica ^a   Vitale Brovarone, Chiara ^a  

^a POLITECNICO DI TORINO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IRCCS   (Italy)

^d International Centre for Studies and Research in Biomedicine (ICB) Asbl   (Luxembourg)

Author keywords

Bioactivity; Biocompatibility; Bone grafting; Drug release; Mesoporous glasses; Tissue engineering

Indexed keywords

CALCIUM; HYDROXYAPATITE; IBUPROFEN; MESOPOROUS BIOACTIVE GLASS; NANOMATERIAL; PHOSPHORUS; SILICON; UNCLASSIFIED DRUG; BIOMATERIAL; DRUG CARRIER; GLASS;

ADSORPTION KINETICS; ARTICLE; BIOCOMPATIBILITY; BONE GRAFT; BONE REGENERATION; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DESORPTION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; ION EXCHANGE; MATERIAL COATING; OSTEOSARCOMA CELL; PARTICLE SIZE; STRUCTURE ANALYSIS; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECT; KINETICS; METHODOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

LAKE VICTORIA MARBURGVIRUS;

BIOCOMPATIBLE MATERIALS; BONE REGENERATION; CELL LINE, TUMOR; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GLASS; HUMANS; IBUPROFEN; KINETICS; TISSUE ENGINEERING;

EID: 84863930052     PISSN: None     EISSN: 22808000     Source Type: Journal    
DOI: 10.5301/JABFM.2012.9270     Document Type: Article

References (41)

1. Haber J. Manual on catalyst characterization. Pure Appl Chem 1991; 63: 1227-46.
2. Grun M, Unger KK, Matsumoto A, Tsutsumi K. Novel pathways for the preparation of mesoporous MCM-41 materials: control of porosity and morphology. Microporous Mesoporous Mater 1999; 27: 207-16.
3. Soler-Illia GJDA, Crepaldi EL, Grosso D, Sanchez C. Block copolymer-templated mesoporous oxides. Curr Opin Colloid Interface Sci 2003; 8: 109-26.
4. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992; 359: 710-2.
5. Zhao D, Huo Q, Feng J, Chmelka BF, Stucky DJ. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc 1998; 120: 6024-36.
6. Vallet-Regì M, Ramila A, Del Real R, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater 2001; 13: 308-11.
7. Cauda V, Fiorilli S, Onida B, et al. SBA-15 ordered mesoporous silica inside a bioactive glass-ceramic scaffold for local drug delivery. J Mater Sci Mater Med 2008; 19: 3303-10.
8. Mortera R, Onida B, Fiorilli S, et al. Synthesis of MCM-41 spheres inside bioactive glass-ceramic scaffold. Chem Eng J 2008; 137: 54-61.
9. Vitale-Brovarone C, Baino F, Miola M, Mortera R, Onida B, Verné E. Glass-ceramic scaffolds containing silica mesophases for bone grafting and drug delivery. J Mater Sci Mater Med 2009; 20: 809-20.
10. Mortera R, Baino F, Croce G, et al. Monodisperse mesoporous silica spheres inside a bioactive macroporous glassceramic scaffold. Adv Eng Mater 2010; 12: 256-9.
11. Vallet-Regi M, Izquierdo-Barba I, Ramila A, Perez-Pariente J, Babonneau F, Gonzalez-Calbet J. Phosphorous-doped MCM-41 as bioactive material. Solid State Sci 2005; 7: 233-7.
12. Horcajada P, Ramila A, Boulahya K, Gonzalez-Calbet J, Vallet-Regi M. Bioactivity in ordered mesoporous materials. Solid State Sci 2004; 6: 1295-300.
13. Ozawa N, Negami S, Odaka T, Morii T, Koshino T. Histological observations on tissue reaction of the rat calcaneal tendon to sintered hydroxyapatite. J Mater Sci Lett 1989; 8: 869-71.
14. Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials 2010; 31: 1465-85.
15. Hench LL. Bioactive materials: the potential for tissue regeneration. J Biomed Mater Res Part A 1998; 41: 511-8.
16. Baino F, Vitale-Brovarone C. Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future. J Biomed Mater Res Part A 2011; 97: 514-35.
17. Hench LL, Splinter RJ, Allen WC, Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res Part A 1972; 5: 117-41.
18. Vallet-Regi M, Ragel CV, Salinas AJ. Glasses with medical application. Eur J Inorg Chem 1993; 6: 1029-42.
19. Pereira MM, Clark AE, Hench LL. Calcium phosphate formation on sol-gel-derived bioactive glasses in vitro. J Biomed Mater Res Part A 1994; 28: 693-8.
20. Hench LL. Sol-gel materials for bioceramics applications. Curr Opin Solid State Mater Sci 1997; 2: 604-10.
21. Xia W, Chang J. Well ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release 2006; 110: 522-30.
22. Xia W, Chang J. Preparation, in vitro bioactivity and drug release property of well ordered 58S bioactive glass. J Non Cryst Solids 2008; 354: 1338-41.
23. Lopez-Noriega A, Arcos D, Izquiendo-Barba I, Sakamoto Y, Terasaki O, Vallet-Regi M. Ordered mesoporus bioactive glasses for bone tissue regeneration. Chem Mater 2006; 18: 3137-44.
24. Shi QH, Wang JF, Zhang JP, Fan J, Stucky GD. Rapid-setting, mesoporous, bioactive glass cements that induce accelerated in vitro apatite formation. Adv Mater 2006; 18: 1038-42.
25. Brinker CJ, Lu YF, Sellinger A, Fan HY. Evaporation-induced self-assembly: nanostructures made easy. Adv Mater 1999; 11: 579-85.
26. Yan X, Yu C, Zhou X, Tang J, Zhao D. Highly ordered mesoporus bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed Engl 2004; 43: 5980-4
27. Brunauer S, Emmet PH, Teller E. Adsorption of gases in multimolecular layers. J Am Chem Soc 1938; 60: 309-19.
28. Broekhoff JCP, De Boer JH. Studies on pore systems in catalysts: IX. Calculation of pore distributions from the adsorption branch of nitrogen sorption isotherms in the case of open cylindrical pores A. Fundamental equations. Journal of Catalysis 1967; 9: 8-14.
29. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006; 27: 2907-15.
30. Kuo TC, Lee BS, Kang SH, Lin FH, Lin CP. Cytotoxicity of DP-Bioglass paste used for the treatment of dentin hypersensitivity. J Endod 2007; 33: 451-4.
31. Satterfield CN. Heterogeneous catalysis in industrial practice. New York: Mc Graw-Hill 1991.
32. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses Part A. J Biomed Mater Res 1981; 15: 805-17.
33. Cao W, Hench LL. Bioactive materials. Ceramics International 1996; 22: 493-507.
34. Hench LL, Wilson J. An introduction to bioceramics. Singapore: World Scientific 1993.
35. Sepulveda P, Jones JR, Hench LL. In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses. J Biomed Mater Res Part A 2002; 61: 301-11.
36. Pereira MM, Jones JR, Hench LL. Bioactive glass and hybrid scaffolds prepared by sol-gel method for bone tissue engineering. Adv Appl Ceram 2005; 104: 35-42.
37. Izquierdo-Barba I, Sousa E, Doadrio J, et al. Influence of mesoporous structure type on the controller delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15. Journal of Sol-Gel Science and Technology 2009; 50: 421-9.
38. Hench LL. Genetic design of bioactive glasses. J Eur Ceram Soc 2008; 29: 1257-65.
39. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000; 67: 321-9.
40. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Geneexpression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res Part A 2001; 55: 151-7.
41. Hench LL, Xynos ID, Polak JM. Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 2004; 15: 543-62.